Total Payments
$61,425
2024 Payments
$3,984
Companies
26
Transactions
187
Medicare Patients
1,103
Medicare Billing
$142,834
Payment Breakdown by Category
Other$28,950 (47.1%)
Consulting$20,400 (33.2%)
Travel$7,620 (12.4%)
Food & Beverage$4,455 (7.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $28,950 | 11 | 47.1% |
| Consulting Fee | $20,400 | 9 | 33.2% |
| Travel and Lodging | $7,620 | 11 | 12.4% |
| Food and Beverage | $4,455 | 156 | 7.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Covidien LP | $28,748 | 27 | $0 (2020) |
| FUJIFILM Healthcare Americas Corporation | $17,325 | 8 | $0 (2023) |
| Medtronic, Inc. | $9,846 | 8 | $0 (2024) |
| Boston Scientific Corporation | $2,481 | 5 | $0 (2022) |
| ABBVIE INC. | $494.79 | 26 | $0 (2024) |
| Gilead Sciences, Inc. | $473.95 | 21 | $0 (2024) |
| PFIZER INC. | $378.97 | 14 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $299.88 | 15 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $298.49 | 7 | $0 (2023) |
| Janssen Biotech, Inc. | $214.04 | 13 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,984 | 15 | Medtronic, Inc. ($3,686) |
| 2023 | $11,810 | 22 | FUJIFILM Healthcare Americas Corporation ($10,125) |
| 2022 | $11,517 | 23 | FUJIFILM Healthcare Americas Corporation ($7,200) |
| 2021 | $1,220 | 17 | Medtronic, Inc. ($900.00) |
| 2020 | $3,083 | 22 | Covidien LP ($2,709) |
| 2019 | $4,277 | 20 | Covidien LP ($3,750) |
| 2018 | $13,452 | 34 | Covidien LP ($10,844) |
| 2017 | $12,083 | 34 | Covidien LP ($11,445) |
All Payment Transactions
187 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $32.36 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | Medtronic, Inc. | PILLCAM (Device) | Food and Beverage | In-kind items and services | $85.69 | General |
| Category: Capsule Endoscopy | ||||||
| 08/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/16/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $17.85 | General |
| Category: THERAPY FOR CSID | ||||||
| 06/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $29.94 | General |
| Category: IMMUNOLOGY | ||||||
| 05/31/2024 | Cook Medical LLC | HEMOSPRAY (Device) | Food and Beverage | Cash or cash equivalent | $23.49 | General |
| Category: Endoscopy | ||||||
| 05/24/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.62 | General |
| 05/10/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/26/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: IMMUNOLOGY | ||||||
| 04/19/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $22.46 | General |
| Category: Neuroscience | ||||||
| 04/05/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/29/2024 | Medtronic, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
| 02/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.82 | General |
| Category: Immunology | ||||||
| 01/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/13/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.92 | General |
| 11/15/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Gastroenterology | ||||||
| 11/03/2023 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $25.72 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/02/2023 | Medtronic, Inc. | PILLCAM (Device) | Consulting Fee | Cash or cash equivalent | $450.00 | General |
| Category: Capsule Endoscopy | ||||||
| 10/27/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Immunology | ||||||
| 09/15/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/18/2023 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: IMMUNOLOGY | ||||||
| 08/01/2023 | Medtronic, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| 07/28/2023 | FUJIFILM Healthcare Americas Corporation | FUJIFILM (Device) | Consulting Fee | Cash or cash equivalent | $7,200.00 | General |
| Category: Medical Device | ||||||
| 07/28/2023 | FUJIFILM Healthcare Americas Corporation | FUJIFILM (Device) | Travel and Lodging | In-kind items and services | $2,250.00 | General |
| Category: Medical Device | ||||||
| 07/21/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $25.45 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 156 | 177 | $73,235 | $22,024 |
| 2022 | 12 | 283 | 326 | $147,058 | $36,652 |
| 2021 | 13 | 334 | 376 | $155,686 | $40,944 |
| 2020 | 13 | 330 | 367 | $157,473 | $43,214 |
Total Patients
1,103
Total Services
1,246
Medicare Billing
$142,834
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 44378 | Control of bleeding of small bowel using an endoscope | Facility | 2023 | 32 | 32 | $28,416 | $9,569 | 33.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 31 | 32 | $14,400 | $4,084 | 28.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 37 | 37 | $14,041 | $3,251 | 23.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 18 | 37 | $5,994 | $2,298 | 38.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 20 | 21 | $5,995 | $1,526 | 25.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 18 | $4,389 | $1,297 | 29.5% |
| 44378 | Control of bleeding of small bowel using an endoscope | Facility | 2022 | 29 | 31 | $27,972 | $9,244 | 33.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 61 | 61 | $22,796 | $6,038 | 26.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 43 | 51 | $13,814 | $3,596 | 26.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 20 | 21 | $9,632 | $3,301 | 34.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 26 | 51 | $8,392 | $2,837 | 33.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 14 | 14 | $14,492 | $2,783 | 19.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 11 | 12 | $11,670 | $1,669 | 14.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 11 | 11 | $8,269 | $1,650 | 19.9% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 12 | 14 | $5,844 | $1,634 | 28.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 18 | 18 | $15,111 | $1,356 | 9.0% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Facility | 2022 | 12 | 14 | $3,844 | $1,258 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 14 | $2,796 | $692.80 | 24.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 14 | 14 | $2,426 | $592.86 | 24.4% |
| 44378 | Control of bleeding of small bowel including lower small intestine (ileum) with biopsies, using an endoscope | Facility | 2021 | 25 | 26 | $24,050 | $7,757 | 32.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 39 | 41 | $19,024 | $6,517 | 34.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 54 | 54 | $20,250 | $5,808 | 28.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 32 | 55 | $9,185 | $3,157 | 34.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 36 | 42 | $10,332 | $3,079 | 29.8% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Facility | 2021 | 22 | 23 | $6,854 | $2,368 | 34.6% |
About Dr. Daniel Raines, M.D
Dr. Daniel Raines, M.D is a Gastroenterology healthcare provider based in Kenner, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1316081367.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Raines, M.D has received a total of $61,425 in payments from pharmaceutical and medical device companies, with $3,984 received in 2024. These payments were reported across 187 transactions from 26 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($28,950).
As a Medicare-enrolled provider, Raines has provided services to 1,103 Medicare beneficiaries, totaling 1,246 services with total Medicare billing of $142,834. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Kenner, LA
- Active Since 02/15/2007
- Last Updated 10/23/2008
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1316081367
Products in Payments
- FUJIFILM (Device) $17,325
- PillCam (Device) $9,104
- Barrx (Device) $5,977
- Smart Pill (Device) $5,293
- GENERAL ENDOCHOICE (Device) $2,100
- PILLCAM (Device) $620.55
- XELJANZ (Drug) $297.19
- ENTYVIO (Biological) $248.59
- XIFAXAN (Drug) $206.18
- STELARA (Biological) $197.56
- THERAPIES (Device) $176.72
- Cimzia (Drug) $139.34
- SKYRIZI (Biological) $134.24
- Creon (Drug) $123.46
- ZEPOSIA (Drug) $115.84
- Acquire (Device) $105.08
- RELISTOR (Drug) $92.31
- CREON (Drug) $87.14
- INFLECTRA (Biological) $81.78
- INJECTAFER (Drug) $78.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.